Boehringer Ingelheim Receives Positive CHMP Recommendation for Nerandomilast in IPF and PPF

European Medicines Agency (EMA) has adopted a positive opinion recommending approval of nerandomilast for the treatment of idiopathic pulmonary fibrosis ...

May 25, 2026 | Monday | News
Novo Nordisk Receives Positive CHMP Opinion for Wegovy® 7.2 mg Single-Dose Pen in the EU

Wegovy® 7.2 mg in a single-dose pen has now been recommended by CHMP for approval in the EU Novo Nordisk expects to launch Wegovy® 7.2 mg in a...

May 25, 2026 | Monday | News
Pharming Group Receives European Commission Approval for Joenja® for Activated PI3K Delta Syndrome in the EU

Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS),...

May 25, 2026 | Monday | News
United Immunity Acquires Carisma Therapeutics Assets to Advance In Vivo CAR-M Therapies for Solid Tumors and Fibrosis

 United Immunity, Co., Ltd., a biotechnology company developing its proprietary Myeloid Targeting Platform™ for therapeutic in vivo engineerin...

May 22, 2026 | Friday | News
EpiCypher and New England Biolabs Expand Strategic Partnership to Advance Next-Generation Epigenomics Tools

EpiCypher® and New England Biolabs® (NEB®)  announced an expanded strategic partnership to co-develop next-generation tools for epigenom...

May 21, 2026 | Thursday | News
Thermo Fisher Scientific Opens Advanced Bioanalytical and Biomarker Laboratory in Sweden

The state-of-the-art facility enhances support for complex modalities across all phases of drug development Key facts Thermo Fisher opens new bioanal...

May 21, 2026 | Thursday | News
ProtaGene and Merck KGaA Partner to Deliver End-to-End Biopharmaceutical Testing Solutions

ProtaGene announced a strategic partnership with the Life Science business of Merck, which operates as MilliporeSigma in the United States and Canada, to...

May 21, 2026 | Thursday | News
Sanofi’s Phase 2 ElevAATe Data Show Efdoralprin Alfa Superior to Standard Augmentation Therapy in AATD

ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD ...

May 20, 2026 | Wednesday | News
SERB Pharmaceuticals Acquires European and MENA Rights to Idefirix® from Hansa Biopharma in €115 Million Deal

SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) announced that they have entered into an ...

May 20, 2026 | Wednesday | News
Virtual Science AI Launches Industry-First Medical Competitor AI Platform for Pharma Launch Intelligence

Virtual Science AI announces the launch of Medical Competitor AI, an AI solution that analyses competitor medical activity and scientific narratives. The...

May 19, 2026 | Tuesday | News
Vetter Breaks Ground on Major Saarlouis Expansion to Accelerate Global Injectable Drug Manufacturing Capacity

Ceremonial groundbreaking kicks off the first construction phase Pharmaceutical service provider advances its expansion with a 50,000 sqm facility S...

May 15, 2026 | Friday | News
IBA Unveils AdaPTinsight XR to Advance Precision Imaging Across Proteus® Proton Therapy Systems

Proton therapy CBCT imaging solution across Proteus® Portfolio providing clarity and confidence in IGPT  IBA (Ion Beam Applications S.A., EURON...

May 14, 2026 | Thursday | News
Roche Secures CE Mark for First Single-Assay Blood Test to Rule In and Rule Out Alzheimer’s Pathology

Roche has received CE Mark approval for Elecsys® pTau217, a blood-based diagnostic test designed to detect phosphorylated Tau (pTau) 217 protein, a k...

May 13, 2026 | Wednesday | News
Basel Area Business & Innovation Partners with Roche Korea, KHIDI and KIBO to Accelerate Global Biotech Expansion

New collaboration strengthens connections across the global biotech ecosystem Basel Area Business & Innovation, the strategic growth partner helping...

May 07, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close